Enterprise Value
37.29M
Cash
11.32M
Avg Qtr Burn
-3.597M
Short % of Float
1.49%
Insider Ownership
12.20%
Institutional Own.
22.36%
Qtr Updated
03/31/24
Drug Pipeline
Powered by
![](/BPIQ_Pill.png)
Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|---|---|
MT-401 Details Acute myeloid leukemia | Phase 2 Data readout | |
Neldaleucel/ MT-601 Details Non-Hodgkin lymphoma, Cancer | Phase 1 Data readout | |
Neldaleucel /MT-601 (w/ chemotherapy) Details Pancreatic cancer | Phase 1 Initiation | |
MT-401-OTS Details Acute myeloid leukemia | Phase 1 Initiation |